24.60

3.61% -0.92

After Hours: 25.05 0.45 +1.83%

Castle Biosciences Inc (CSTL)

Overview News Price History Option Chain Financials Why CSTL Down? Discussions Forecast

Castle Biosciences Inc stock is traded at $24.60, with a volume of 396.27K. It is down -3.61% in the last 24 hours and down -0.97% over the past month. Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Previous Close:

$25.52

Open:

$25.43

24h Volume:

396.27K

Relative Volume:

1.09

Market Cap:

$745.28M

Revenue:

$344.23M

Net Income/Loss:

$-24.16M

P/E Ratio:

-29.04

EPS:

-0.8471

Net Cash Flow:

$28.33M

1W Performance:

-0.36%

1M Performance:

-0.97%

6M Performance:

-26.72%

1Y Performance:

+31.20%

1-Day Range:

$24.43

$25.50

1-Week Range:

$23.31

$25.70

52-Week Range:

$14.59

$44.28

Castle Biosciences Inc Stock (CSTL) Company Profile

Name

Castle Biosciences Inc

Sector

Healthcare (1106)

Industry

Diagnostics & Research (52)

Phone

866-788-9007

Address

1500 W. PARKWOOD AVE., FRIENDSWOOD, TX

Employee

883

Twitter

@castlebio

Next Earnings Date

2026-05-06

Latest SEC Filings

CSTL's Discussions on Twitter

Compare CSTL vs TMO, DHR, IDXX, WAT, A

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CSTL Castle Biosciences Inc	24.60	773.15M	344.23M	-24.16M	28.33M	-0.8471
TMO Thermo Fisher Scientific Inc	466.76	171.91B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	174.63	123.18B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	562.97	44.73B	4.30B	1.06B	1.04B	13.08
WAT Waters Corp	342.75	29.63B	3.17B	642.63M	516.49M	10.77
A Agilent Technologies Inc	117.53	31.70B	7.07B	1.29B	993.00M	4.5355

Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-14-23	Initiated	Guggenheim	Buy
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Jan-07-22	Initiated	Stephens	Overweight
Apr-30-21	Initiated	Lake Street	Buy
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Dec-27-19	Reiterated	Canaccord Genuity	Buy
Aug-19-19	Initiated	BTIG Research	Buy
Aug-19-19	Initiated	Canaccord Genuity	Buy
Aug-19-19	Initiated	Robert W. Baird	Outperform
Aug-19-19	Initiated	SVB Leerink	Outperform

View All

Castle Biosciences Inc Stock (CSTL) Latest News

09:55 AM

Wall Street Analysts Predict an 85.15% Upside in Castle Biosciences (CSTL): Here's What You Should Know - Yahoo Finance Singapore

09:55 AM

07:03 AM

Free skin cancer screenings roll out nationwide with Castle support - Stock Titan

07:03 AM

May 04, 2026

Castle Biosciences to present new Mayo Clinic research on TissueCypher test at Digestive Disease Week - Traders Union

May 04, 2026

Mayo Clinic data: Barrett's test changed surveillance in 55% - Stock Titan

May 04, 2026

May 02, 2026